In this issue:
Adjuvant vs early salvage RT in pT3NO prostate cancer
Adjuvant RT in lymph nodepositive prostate cancer
Adjuvant vs salvage RT after radical prostatectomy
Tissue-based molecular testing in localised prostate cancer
Long-term outcomes after bladder-preserving trimodal therapy
Trimodal therapy vs radical cystectomy for muscle-invasive urothelial carcinoma of the bladder
Adjustable transobturator male system (ATOMS)
Factors related to noncancer related transurethral prostatectomy
Percutaneous nephrolithotomy access by urologist or interventional radiologist
First-line sunitinib vs pazopanib in metastatic renal cell carcinoma
Please login below to download this issue (PDF)